These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 32169380)

  • 21. Effect of levocetirizine on nasal provocation testing with adenosine monophosphate compared with allergen challenge in allergic rhinitis.
    Vaidyanathan S; Nair A; Barnes ML; Meldrum K; Lipworth BJ
    Clin Exp Allergy; 2009 Mar; 39(3):409-16. PubMed ID: 19187327
    [TBL] [Abstract][Full Text] [Related]  

  • 22. EAACI Position paper on the standardization of nasal allergen challenges.
    Augé J; Vent J; Agache I; Airaksinen L; Campo Mozo P; Chaker A; Cingi C; Durham S; Fokkens W; Gevaert P; Giotakis A; Hellings P; Herknerova M; Hox V; Klimek L; La Melia C; Mullol J; Muluk NB; Muraro A; Naito K; Pfaar O; Riechelmann H; Rondon C; Rudenko M; Samolinski B; Tasca I; Tomazic P; Vogt K; Wagenmann M; Yeryomenko G; Zhang L; Mösges R
    Allergy; 2018 Aug; 73(8):1597-1608. PubMed ID: 29377177
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Environmental priming influences allergen-specific nasal reactivity.
    Toth J; Schultze-Werninghaus C; Marks B; Temmel AF; Stübner P; Jäger S; Horak F
    Allergy; 1998 Dec; 53(12):1172-7. PubMed ID: 9930593
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Peak nasal inspiratory flow as outcome for provocation studies in allergen exposure chambers: a GA
    Boelke G; Berger U; Bergmann KC; Bindslev-Jensen C; Bousquet J; Gildemeister J; Jutel M; Pfaar O; Sehlinger T; Zuberbier T
    Clin Transl Allergy; 2017; 7():33. PubMed ID: 28932387
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Optimisation of grass pollen nasal allergen challenge for assessment of clinical and immunological outcomes.
    Scadding GW; Calderon MA; Bellido V; Koed GK; Nielsen NC; Lund K; Togias A; Phippard D; Turka LA; Hansel TT; Durham SR; Wurtzen PA
    J Immunol Methods; 2012 Oct; 384(1-2):25-32. PubMed ID: 22759401
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Measurement of changes in mRNA for IL-5 in noninvasive scrapings of nasal epithelium taken from patients undergoing nasal allergen challenge.
    Dreskin SC; Dale SN; Foster SM; Martin D; Buchmeier A; Nelson HS
    J Immunol Methods; 2002 Oct; 268(2):189-95. PubMed ID: 12215387
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Rush immunotherapy results in allergen-specific alterations in lymphocyte function and interferon-gamma production in CD4+ T cells.
    Lack G; Nelson HS; Amran D; Oshiba A; Jung T; Bradley KL; Giclas PC; Gelfand EW
    J Allergy Clin Immunol; 1997 Apr; 99(4):530-8. PubMed ID: 9111499
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Fel d 1-derived synthetic peptide immuno-regulatory epitopes show a long-term treatment effect in cat allergic subjects.
    Couroux P; Patel D; Armstrong K; Larché M; Hafner RP
    Clin Exp Allergy; 2015 May; 45(5):974-981. PubMed ID: 25600085
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Sensitization to Cat: When Is Nasal Challenge Needed?
    Al-Ahmad M; Jusufovic E; Arifhodzic N; Nurkic J; Hanoun AL
    Int Arch Allergy Immunol; 2019; 179(2):108-113. PubMed ID: 30970353
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Role of nasal challenge and local eosinophilia in indirect exposure to cat in allergic rhinitis patients.
    Al Ahmad M; Arifhodzic N; Nurkic J; Jusufovic E; Hanoun AL; Rodriguez T
    Eur Ann Allergy Clin Immunol; 2018 May; 50(3):125-131. PubMed ID: 29479937
    [No Abstract]   [Full Text] [Related]  

  • 31. Comparing the nasal allergen challenge and environmental exposure unit models of allergic rhinitis.
    Ramchandani R; Linton S; Hossenbaccus L; Ellis AK
    Ann Allergy Asthma Immunol; 2021 Aug; 127(2):163-164. PubMed ID: 33848630
    [No Abstract]   [Full Text] [Related]  

  • 32. Effects of combination treatment with tezepelumab and allergen immunotherapy on nasal responses to allergen: A randomized controlled trial.
    Corren J; Larson D; Altman MC; Segnitz RM; Avila PC; Greenberger PA; Baroody F; Moss MH; Nelson H; Burbank AJ; Hernandez ML; Peden D; Saini S; Tilles S; Hussain I; Whitehouse D; Qin T; Villarreal M; Sever M; Wheatley LM; Nepom GT; Sanda S;
    J Allergy Clin Immunol; 2023 Jan; 151(1):192-201. PubMed ID: 36223848
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Combined diesel exhaust particulate and ragweed allergen challenge markedly enhances human in vivo nasal ragweed-specific IgE and skews cytokine production to a T helper cell 2-type pattern.
    Diaz-Sanchez D; Tsien A; Fleming J; Saxon A
    J Immunol; 1997 Mar; 158(5):2406-13. PubMed ID: 9036991
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of omalizumab on changes in pulmonary function induced by controlled cat room challenge.
    Corren J; Wood RA; Patel D; Zhu J; Yegin A; Dhillon G; Fish JE
    J Allergy Clin Immunol; 2011 Feb; 127(2):398-405. PubMed ID: 21281870
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Birch-induced allergic rhinitis: Results of exposure during nasal allergen challenge, environmental chamber, and pollen season.
    Gherasim A; Dietsch F; Beck M; Domis N; de Blay F
    World Allergy Organ J; 2023 Jul; 16(7):100801. PubMed ID: 37520615
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Protective effect of montelukast on lower and upper respiratory tract responses to short-term cat allergen exposure.
    Perry TT; Corren J; Philip G; Kim EH; Conover-Walker MK; Malice MP; Massaad R; Dass SB; Reiss TF; Wood RA
    Ann Allergy Asthma Immunol; 2004 Nov; 93(5):431-8. PubMed ID: 15562881
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Efficacy of the oral chemoattractant receptor homologous molecule on TH2 cells antagonist BI 671800 in patients with seasonal allergic rhinitis.
    Krug N; Gupta A; Badorrek P; Koenen R; Mueller M; Pivovarova A; Hilbert J; Wetzel K; Hohlfeld JM; Wood C
    J Allergy Clin Immunol; 2014 Feb; 133(2):414-9. PubMed ID: 24332218
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Intranasal fluticasone propionate inhibits recovery of chemokines and other cytokines in nasal secretions in allergen-induced rhinitis.
    Weido AJ; Reece LM; Alam R; Cook CK; Sim TC
    Ann Allergy Asthma Immunol; 1996 Nov; 77(5):407-15. PubMed ID: 8933780
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of natural seasonal pollen exposure and repeated nasal allergen provocations on elevation of exhaled nitric oxide.
    Bergmann-Hug K; Wirth R; Henseler M; Helbling A; Pichler WJ; Schnyder B
    Allergy; 2009 Nov; 64(11):1629-34. PubMed ID: 19627276
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Nasal mucosal blood flow after intranasal allergen challenge.
    Holmberg K; Bake B; Pipkorn U
    J Allergy Clin Immunol; 1988 Mar; 81(3):541-7. PubMed ID: 3346485
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.